FDA Unveils User Fee Program for Generics – Drug Discovery & Development

January 16, 2012 Posted By: Leave a comment
Up until 2010, the FDA did not have authority to approve knock-off versions of biotech drugs, or biosimilars ... But the Obama administration's health reform law signed into law in March 2010 instructed the FDA to begin reviewing and approving ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>